174 related articles for article (PubMed ID: 28791396)
1. Oxidored-nitro domain-containing protein 1 promotes liver fibrosis by activating the Wnt/β-catenin signaling pathway in vitro.
Xiang T; Zhang S; Cheng N; Ge S; Wen J; Xiao J; Wu X
Mol Med Rep; 2017 Oct; 16(4):5050-5054. PubMed ID: 28791396
[TBL] [Abstract][Full Text] [Related]
2. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway.
Huang W; Li L; Tian X; Yan J; Yang X; Wang X; Liao G; Qiu G
Mol Med Rep; 2015 Apr; 11(4):2569-77. PubMed ID: 25435153
[TBL] [Abstract][Full Text] [Related]
3. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation.
Ge WS; Wang YJ; Wu JX; Fan JG; Chen YW; Zhu L
Mol Med Rep; 2014 Jun; 9(6):2145-51. PubMed ID: 24691643
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
5. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
[TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
[TBL] [Abstract][Full Text] [Related]
8. EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis.
Yang Y; Chen XX; Li WX; Wu XQ; Huang C; Xie J; Zhao YX; Meng XM; Li J
J Cell Mol Med; 2017 Oct; 21(10):2317-2328. PubMed ID: 28332284
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
[TBL] [Abstract][Full Text] [Related]
10. Curcumin raises lipid content by Wnt pathway in hepatic stellate cell.
Zhang F; Lu C; Xu W; Shao J; Wu L; Lu Y; Zheng S
J Surg Res; 2016 Feb; 200(2):460-6. PubMed ID: 26414021
[TBL] [Abstract][Full Text] [Related]
11. Astaxanthin prevents TGFβ1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells.
Yang Y; Kim B; Park YK; Koo SI; Lee JY
Biochim Biophys Acta; 2015 Jan; 1850(1):178-85. PubMed ID: 25450180
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of HIPK2 attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
He P; Yu ZJ; Sun CY; Jiao SJ; Jiang HQ
Biomed Pharmacother; 2017 Jan; 85():575-581. PubMed ID: 27890429
[TBL] [Abstract][Full Text] [Related]
13. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1 gene silencing inhibits the activation and proliferation but induces the apoptosis of hepatic stellate cells from mice with liver fibrosis.
Jiang ZJ; Shen QH; Chen HY; Yang Z; Shuai MQ; Zheng SS
Int J Mol Med; 2019 Jan; 43(1):103-116. PubMed ID: 30365068
[TBL] [Abstract][Full Text] [Related]
15. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling.
Li J; Wang Y; Ma M; Jiang S; Zhang X; Zhang Y; Yang X; Xu C; Tian G; Li Q; Wang Y; Zhu L; Nie H; Feng M; Xia Q; Gu J; Xu Q; Zhang Z
EBioMedicine; 2019 Feb; 40():43-55. PubMed ID: 30639416
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells.
Qian J; Niu M; Zhai X; Zhou Q; Zhou Y
Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
Akcora BÖ; Storm G; Bansal R
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
[TBL] [Abstract][Full Text] [Related]
18. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of receptor for advanced glycation end product‑specific small interfering RNAs on the development of hepatic fibrosis in primary rat hepatic stellate cells.
Xia JR; Chen TT; Li WD; Lu FL; Liu J; Cai XG; Lu Q; Yang CP
Mol Med Rep; 2015 Jul; 12(1):569-74. PubMed ID: 25673150
[TBL] [Abstract][Full Text] [Related]
20. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
